Latest data out on tissue and cell-related device problems faced by EU authorities
This article was originally published in Clinica
Executive Summary
Labeling issues, contaminated media, storage problems and illegal and fraudulent activities safety and quality. These are among some of the reason for recalls and alerts related to tissue and cell-based medical products which were reported to the European Commission between 2010 and 2012.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.